SYS-CON MEDIA Authors: Cynthia Dunlop, Mark O'Neill, Kevin Benedict, RealWire News Distribution, Gilad Parann-Nissany

News Feed Item

LED Medical Announces US Distribution Agreement with Benco Dental

BURNABY, BRITISH COLUMBIA -- (Marketwired) -- 12/10/13 -- LED Medical Diagnostics Inc. ("LED Medical" or the "Company") (TSX VENTURE: LMD)(OTCQX: LEDIF)(FRANKFURT: LME) is pleased to announce that its wholly-owned subsidiary, LED Dental Inc. ("LED Dental"), has entered into a non-exclusive partnership with Benco Dental ("Benco") for the distribution of the Company's VELscope® Vx Enhanced Oral Assessment System and product line within the United States market.

"We are pleased to partner with Benco for distribution in the United States," stated Dr. David Gane, CEO for LED Medical. "Benco currently serves more than 35,000 customers across the country and maintains an excellent reputation in the dental industry. We are excited about the opportunity to work together, maximizing the significant sales potential for the VELscope® Vx product line through its extensive network."

"We are pleased to now carry the VELscope® Vx product line for our customers," states Chuck Cohen, Managing Director of Benco Dental. "LED Dental has established itself as the market leader for tissue fluorescence visualization in the dental industry and the VELscope® Vx system has proven itself as the top adjunctive device available for the early discovery of a wide range oral abnormalities including oral cancer. It is a welcome addition to the portfolio of outstanding equipment lines we carry at Benco."

About the VELscope® Vx Enhanced Oral Assessment System

The distinctive blue-spectrum light of the VELscope® Vx hand-held device causes the soft tissues of the mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns that are visibly disrupted by trauma or disease, such as neoplastic lesions, chemical irritation, side-effects from medication, thermal damage, fungal, viral or bacterial infections. Use of the VELscope® Vx allows a wide variety of oral abnormalities to be discovered, often before they're visible to the unassisted eye. It is also the only tissue fluorescence device with photo/video documentation capabilities through the viewing mechanism, a key function for referrals and patient records.

About Benco Dental Supply Company

Benco Dental, headquartered in Northeastern Pennsylvania, is the largest privately-owned dental company in the United States, offering a full array of supplies, equipment and services to dentists across the nation. Founded in 1930 by Benjamin Cohen, the company has remained family-owned and focused on its unique mission to 'deliver success, smile after smile.' Over the past decade, Benco has been the nation's fastest growing dental distributor, now servicing more than 35,000 dentists and dental laboratories.

Within the past 83 years, the company has grown from a single downtown location to a national network of more than 65 regional locations, five distribution centers, and two design showrooms. Those design showrooms, one at the company's PA headquarters and one in Southern California, feature North America's largest selection of dental equipment and technology, as well as a hands-on dental design experience, to assist dentists in the planning and construction of a new office.

Benco is proud to boast a highly skilled team of more than 400 professionally trained sales representatives and over 300 factory-trained service technicians. For more information, visit benco.com or call 1.800.GO.BENCO.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED-based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, visit www.ledmd.com.

Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures the VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope® Vx devices are now used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. To date, there have been more than 12,000 VELscope® Vx systems sold globally and they have been used to perform more than 25 million exams. For more information, call 604.434.4614 or visit www.leddental.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
For media or investor relations, please contact:
LED Medical Diagnostics Inc.
Mark Komonoski, Investor Relations
(403) 255-8483 or Toll-Free: (877) 255-8483
Cell: (403) 470-8384
mark.komonoski@ledmd.com / Skype: mkomonoski

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.